针对拓酶II的抗癌药物用于抗真菌治疗
Kavya Kondaka1, Kamila Rząd1, Natalia Maciejewska1
1Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, 11/12 Narutowicza Str, Gdansk, 80-233, Poland.
Scientific reports
|March 19, 2025
概括
一些针对人体拓酶II的抗癌药物显示出作为新型抗真菌剂的前景. 伊达鲁比辛有效地抑制了真菌拓酶II和真菌生长,这表明了新的治疗途径.
科学领域:
- 生物化学 生物化学
- 菌类学 菌类学是指菌类学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 的拓酶II (TopoII) 对于细胞的生存至关重要.
- 迫切需要新的抗真菌疗法来对抗耐药菌株.
研究的目的:
- 探索真菌TopoII作为抗真菌化疗的治疗点.
- 评估针对人类的抗癌药物的抗真菌潜力.
主要方法:
- 选了11种已知抑制人类TopoII的抗癌化合物.
- 评估了酵母TopoII和真菌生长的抑制.
- 研究的作用机制包括DNA碎片化和氧化应激.
主要成果:
- 大多数化合物抑制了酵母TopoII,但很少有人表现出抗真菌活性.
- 伊达鲁比辛证明了强大的真菌生长和酵母TopoII的抑制.
- 伊达鲁比辛,埃皮鲁比辛和比桑特林比人类的TopoII抑制剂更有效的酵母TopoII抑制剂.
- 伊达鲁比辛表现出多方面的机制,包括DNA碎片化和氧化应激.
结论:
- 菌TopoII是抗真菌药物开发的可行目标.
- 伊达鲁比辛和相关化合物显示出作为新型抗真菌剂的起点具有重大潜力.
- 对伊达鲁比机制的进一步研究可能会导致创新的抗真菌疗法.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Electron Transport Chain: Complex I and II
9.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.9K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
DNA Topoisomerases
30.7K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
30.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


